@article{article, title  = {{Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{http://dx.doi.org/10.1038/s41591-023-02639-3 }},

 year = {{2023}},

 month = {{10}},

 author = {{Mummery CJ and Börjesson-Hanson A and Blackburn DJ and Vijverberg EGB and De Deyn PP and Ducharme S and Jonsson M and Schneider A and Rinne JO and Ludolph AC and Bodenschatz R et al}},

 doi = {{10.1038/s41591-023-02639-3}},

 journal = {{Nature Medicine}},

 note = {{Accessed on 2024/12/22}}}